Smile Doctors explores $2 billion debt refinancing to reduce costs — Bloomberg

LootboxPhobia · 2026-03-10T22:37:32+00:00

Smile Doctors LLC is in talks with investors regarding approximately $2 billion in debt refinancing aimed at reducing borrowing costs. The company has appointed Barclays as the lead for a potential transaction, with the current loan interest rate at the federal benchmark plus 5.75%. Discussions are still in the early stages, and the deal is uncertain.

LootboxPhobia

2026-03-10 22:37:32

Abstract generation in progress

Investing.com – According to Bloomberg, citing sources, Smile Doctors LLC is in discussions with investors to refinance approximately $2 billion of debt, aiming to reduce its borrowing costs.

Sources say the dental company has appointed Barclays as the lead arranger for potential transactions in the U.S. leveraged loan market.

Smile Doctors currently holds loans from several private lenders, including Blackstone Inc. and Antares. The existing loans have an interest rate set at 5.75 percentage points above the Federal Reserve’s overnight financing rate benchmark. Sources indicate the company believes that selling the loans to a broader group of investors could result in lower borrowing costs.

The company’s existing debt was financed by an investment from THL in January 2022. Linden acquired a majority stake in Smile Doctors in 2017.

Sources note that discussions are still in the early stages and the deal may not materialize.

This article was translated with AI assistance. For more information, please see our Terms of Use.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.